TECON(SZ:002100)2022-12-08 08:41Group 1: Business Operations - The company employs a "sales-driven production and sales" strategy to effectively control operational risks while leveraging the plant protein business to support the feed business [2] - The feed business in Xinjiang maintains good growth, while the Central Plains region experiences slow growth, and the Northeast region faces significant challenges [3] Group 2: Vaccine Business - The animal vaccine business saw substantial growth in 2014, primarily due to a surge in sales of small ruminant disease vaccines and stable growth in government tendered vaccines [3] - The company is actively seeking breakthroughs in market-oriented marketing for its vaccine products [3] Group 3: Asset Restructuring - The company has submitted feedback to the China Securities Regulatory Commission (CSRC) regarding its major asset restructuring, which is currently under review by the CSRC [3]